Franklin Vanessa J, Bildsoe Heidi, Tam Patrick P L
Embryology Unit, Children's Medical Research Institute, University of Sydney, Wentworthville, NSW 2145, Australia.
CSH Protoc. 2007 Nov 1;2007:pdb.prot4892. doi: 10.1101/pdb.prot4892.
INTRODUCTIONAnalysis of the developmental fate of cell populations in different parts of the embryo enables the construction of fate maps. These reveal the organization of the body plan and can presage the expression of molecular characteristics of cell lineages and the formation of body parts. The efficacy of fate-mapping techniques is critically dependent on their ability to track the cells and all their descendants without compromising the development of the embryo. Cell grafting involves isolating a population of genetically tagged cells from a transgenic embryo and grafting them to a defined site in a nontransgenic host embryo. Tissue colonization is analyzed using a genetic tag (e.g., a fluorescent protein that can be visualized noninvasively) that allows tracking of the transplanted cells and their descendants in the host embryo throughout development in culture. Alternatively, a lacZ transgene can be used to localize graft-derived cells histologically. Differentiation of the graft-derived cells can be studied by examining the expression of molecular markers by in situ hybridization of gene transcripts or immunohistochemical detection of lineage-specific proteins. This protocol describes how to graft cells isolated from a donor embryo into the germ layer of a wild-type host mouse embryo at 7-7.5 days post-coitum (dpc).
引言
分析胚胎不同部位细胞群体的发育命运有助于构建命运图谱。这些图谱揭示了身体蓝图的组织方式,并能预示细胞谱系的分子特征表达和身体部位的形成。命运图谱技术的有效性关键取决于其追踪细胞及其所有后代而不影响胚胎发育的能力。细胞移植包括从转基因胚胎中分离出一群带有遗传标记的细胞,并将它们移植到非转基因宿主胚胎的特定部位。使用遗传标记(例如可以无创可视化的荧光蛋白)分析组织定植情况,该标记可在整个培养发育过程中追踪宿主胚胎中移植的细胞及其后代。另外,可使用lacZ转基因通过组织学方法定位移植来源的细胞。通过基因转录本原位杂交或谱系特异性蛋白的免疫组织化学检测来检查分子标记的表达,从而研究移植来源细胞的分化情况。本方案描述了如何在交配后7 - 7.5天(dpc)将从供体胚胎分离的细胞移植到野生型宿主小鼠胚胎的胚层中。